SNX2 (C-term), 457-485 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-SNX2 (C-term), 457-485 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | SNX2 (C-term), 457-485 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human (predicted reactivity: bovine, monkey, mouse) |
| Isotype | n/a |
| Format | peptide affinity purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 0.5 |
| Applications | Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This SNX2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 457-485 amino acids from the C-terminal region of human SNX2. This gene encodes a member of the sorting nexin family.Members of this family contain a phox (PX) domain, which is aphosphoinositide binding domain, and are involved in intracellulartrafficking. This protein associates with formin-binding protein17, but its function is unknown. This protein may form oligomericcomplexes with family members. |
| Immunogen | n/a |
| Other Names | [Sorting nexin-2; Transformation-related gene 9 protein; TRG-9; SNX2] |
| Gene, Accession # | [SNX2], Gene ID: 6643, NCBI: NP_001265128.1, UniProt: O60749 |
| Catalog # | MBS9208143 |
| Price | $165, $370 |
| Order / More Info | SNX2 (C-term), 457-485 Antibody from MYBIOSOURCE INC. |
| Product Specific References | Skanland, S.S., et al. Traffic 8(3):297-309(2007) Rojas, R., et al. Mol. Cell. Biol. 27(3):1112-1124(2007) Beausoleil, S.A., et al. Nat. Biotechnol. 24(10):1285-1292(2006) Carlton, J.G., et al. J. Cell. Sci. 118 (PT 19), 4527-4539 (2005) : Abdul-Ghani, M., et al. J. Cell. Physiol. 204(1):210-218(2005) |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies